Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

diSArm clinical trial is that our phages injected intravenously can home in to the site of infection, penetrate biofilms, infect, and lyse S. aureus. Many deaths post flu, and most likely also ...

After his company, Colossal Biosciences, successfully revived the dire wolf from extinction, he's ready to continue to change ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

In a separate 2024 study, researchers also made mice temporarily transparent. The study, published in Science, showed that ...

In a vote Tuesday, the International Union for Conservation of Nature (IUCN) approved further exploration of the use of genetic engineering tools to aid in the preservation of animal species and other ...

At a meeting of top conservation groups this week, a bioethics question took center stage: Should scientists be allowed to tinker with the genes of wild plants and animals? The tentative consensus so ...